For instance, carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) are introduced as diagnostic biomarkers, which in turn are used for GC screening; they have low sensitivity, especially at the early stages [10–12]. Here, CEACAM5 is linked to cancer.